PROJECTS
Through publications, collaborative workshops, and educational initiatives, we aim to raise awareness about autoimmune diseases, promote dialogue among stakeholders, and contribute to the advancement of immunological knowledge globally.
FLAMIN–GO
Start date: 01.01.2021
End date: 30.06.2025
Next-generation joint-on-chip
The EU funded research project FLAMIN-GO aims at developing the firs customized joint-on-chip. Such construct is able to recreate, starting from each patient’s biopsies, a three-dimensional in vitro model of the joint of the patient affected by rheumatoid arthritis (RA), for the personalized study of an effective therapy.
FORCE REPAIR
Start date: 01.01.2023
End date: 31.12.2026
Advance chronic wound management
FORCE REPAIR aims to advance chronic wound management by developing a smart, multifunctional, and cost-effective 3D-printed wound dressing that effectively combats bacterial infections and inflammation, promotes healing, and relieves skin tension.
SINPAIN
Start date: 01.05.2022
End date: 31.10.2026
Innovative nanotherapeutics pipeline for the treatment of osteoarthritis
SINPAIN aims to develop a pipeline of siRNA-based therapy built on the combination of current technologies (dynamic IA-HA and nanocarriers) that will be designed step- by-step in order to reach a successful management of inflammation and innervation therapy for the treatment of early (grade 0-1) and later stages (grade 3-4) of knee OA.
TECNOMEDHUB
Start date: 30.05.2022
End date: 31.05.2024
Multi-omics techniques in the medical sciences: artificial intelligence in support of public health
The main objective of the TECNOMED-HUB project is to create, in the Piedmontese territory, a 4.0 technological platform to support medical research.
MIND–ME
Start date: 01.06.2020
End date: 31.05.2023
Microvesicles at the INtersection between Dysbiosis and Major dEpression disorder: an OMIC approach
This proposal seeks to uncover MDD’s molecular basis and discover new biomarkers, enhancing care for non-responsive patients and reducing treatment failures.
PREMUROSA
Start date: 01.01.2020
End date: 31.12.2023
Precision medicine for musculoskeletal regeneration, prosthetics, and active ageing
Premurosa project aims to combine the personalized clinical approach with individual ‘omic’ characterization and proper choice of medical device. This aim will be achieved by a “triple i” (interdisciplinary, intersectoral, international) approach of thirteen ESRs, who will benefit from an excellent scientific environment, up-date technologies and supervision by international leaders in the field.
MINDFUL
Start date: November 2018
End date: November 2022
Microvesicles: INtersection between autoimmune Diseases, Food and Unhealthy Lifestyles
MINDFUL project aims to investigate the relationship between the human gut microbiota and the onset of autoimmune diseases (ADs), by evaluating the contribution of different eating habits and lifestyles in dysbiosis and unravelling the extracellular vesicles (EVs)-mediated communication mechanisms between gut bacteria and immune cells.
PROJECTS
Through publications, collaborative workshops, and educational initiatives, we aim to raise awareness about autoimmune diseases, promote dialogue among stakeholders, and contribute to the advancement of immunological knowledge globally.
FLAMIN–GO
Start date: 01.01.2021
End date: 30.06.2025
Next-generation joint-on-chip
The EU funded research project FLAMIN-GO aims at developing the firs customized joint-on-chip. Such construct is able to recreate, starting from each patient’s biopsies, a three-dimensional in vitro model of the joint of the patient affected by rheumatoid arthritis (RA), for the personalized study of an effective therapy.
FORCE REPAIR
Start date: 01.01.2023
End date: 31.12.2026
Advance chronic wound management
FORCE REPAIR aims to advance chronic wound management by developing a smart, multifunctional, and cost-effective 3D-printed wound dressing that effectively combats bacterial infections and inflammation, promotes healing, and relieves skin tension.
SINPAIN
Start date: 01.05.2022
End date: 31.10.2026
Innovative nanotherapeutics pipeline for the treatment of osteoarthritis
SINPAIN aims to develop a pipeline of siRNA-based therapy built on the combination of current technologies (dynamic IA-HA and nanocarriers) that will be designed step- by-step in order to reach a successful management of inflammation and innervation therapy for the treatment of early (grade 0-1) and later stages (grade 3-4) of knee OA.
TECNOMEDHUB
Start date: 30.05.2022
End date: 31.05.2024
Multi-omics techniques in the medical sciences: artificial intelligence in support of public health
The main objective of the TECNOMED-HUB project is to create, in the Piedmontese territory, a 4.0 technological platform to support medical research.
MIND–ME
Start date: 01.06.2020
End date: 31.05.2023
Microvesicles at the INtersection between Dysbiosis and Major dEpression disorder: an OMIC approach
This proposal seeks to uncover MDD’s molecular basis and discover new biomarkers, enhancing care for non-responsive patients and reducing treatment failures.
PREMUROSA
Start date: 01.01.2020
End date: 31.12.2023
Precision medicine for musculoskeletal regeneration, prosthetics, and active ageing
Premurosa project aims to combine the personalized clinical approach with individual ‘omic’ characterization and proper choice of medical device. This aim will be achieved by a “triple i” (interdisciplinary, intersectoral, international) approach of thirteen ESRs, who will benefit from an excellent scientific environment, up-date technologies and supervision by international leaders in the field.
MINDFUL
Start date: November 2018
End date: November 2022
Microvesicles: INtersection between autoimmune Diseases, Food and Unhealthy Lifestyles
MINDFUL project aims to investigate the relationship between the human gut microbiota and the onset of autoimmune diseases (ADs), by evaluating the contribution of different eating habits and lifestyles in dysbiosis and unravelling the extracellular vesicles (EVs)-mediated communication mechanisms between gut bacteria and immune cells.